Alcon (SIX/NYSE:ALC), a global leader in eye care, announced its financial results for the second quarter and first half of 2024. In Q2 2024, the company achieved sales of $2.5 billion, marking a 3% increase on a reported basis and…
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a nonprofit healthcare provider serving over one million people in Virginia and West Virginia, have announced a major collaboration. Carilion Clinic will implement Philips’ comprehensive…
Actio Biosciences, a biotechnology firm focused on utilizing a novel genetic and precision medicine platform to create therapeutics for both rare and common diseases, has appointed Dr. Dimitrios Arkilo as Chief Medical Officer (CMO). Dr. Arkilo, a pediatric neurologist with…
Amplitude Vascular Systems (AVS), a medical device company specializing in treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy (IVL) platform, has announced a strategic partnership with the Jacobs Institute, a nonprofit medical device innovation center in Buffalo, N.Y.,…
Weave (NYSE: WEAV), a top all-in-one customer experience and payments platform, has clinched its fourth consecutive Dental Product Shopper Readers’ Choice Award for both Patient Communication and Dental Analytics software. Dental Product Shopper, a leading publication in the dental industry,…
QuantHealth, an AI-driven clinical trial design firm, has successfully simulated over 100 trials, achieving 85% accuracy and notable returns on investment for pharmaceutical partners. By utilizing its proprietary technology and patient-focused solutions, the company tackles the common issue of trial…
Relief Mental Health, a top provider of transcranial magnetic stimulation (TMS), psychedelic therapy (including SPRAVATO® and IV ketamine), psychiatry, and talk therapy, has introduced TMS for smoking cessation at its Oak Brook, IL clinic. Relief Mental Health is now offering…
HistoSonics has closed an oversubscribed $102 million Series D financing round, led by Alpha Wave Ventures. New investors Amzak Health and HealthQuest Capital joined existing backers Johnson & Johnson Innovation – JJDC, Inc., Venture Investors, Lumira Ventures, Yonjin Venture, and…
DermBiont, a clinical-stage biotech company specializing in innovative topical treatments for rare oncology and dermatology conditions, has reported promising initial results from its open-label, multi-center Phase 2a trial for basal cell carcinoma (BCC). Following these positive findings, DermBiont is shifting…
AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted by the FDA for Priority Review. This application, based on the positive ADRIATIC Phase III trial results in patients with limited-stage small cell lung cancer (LS-SCLC) whose disease…
Commonwealth Care Alliance (CCA) has expanded its provider agreement with Beth Israel Lahey Health (BILH) to enhance care access for its Senior Care Options (SCO) and One Care members. This expanded network will serve approximately 20 towns and cities in…
Trilliant Health, a top analytics firm in the healthcare sector, has introduced a free version of its Provider Directory application. This user-friendly tool offers a centralized source for precise and up-to-date information on millions of healthcare providers and is now…